Insider Transactions in Q4 2024 at Vor Biopharma Inc. (VOR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2024
|
Reprogrammed Interchange LLC |
BUY
Open market or private purchase
|
Direct |
38,974,101
+50.0%
|
-
|
|
Dec 30
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
16,897,159
+30.88%
|
-
|
|
Dec 27
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,334
-11.26%
|
$10,334
$1.25 P/Share
|
|
Nov 06
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-0.51%
|
$0
$0.86 P/Share
|
|
Nov 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.3%
|
$0
$0.86 P/Share
|
|
Nov 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.08%
|
$0
$0.86 P/Share
|
|
Nov 06
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-0.41%
|
$0
$0.86 P/Share
|
|
Nov 01
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,751
-0.35%
|
$0
$0.8 P/Share
|
|
Nov 01
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.22%
|
$0
$0.8 P/Share
|
|
Nov 01
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
986
-0.57%
|
$0
$0.8 P/Share
|
|
Nov 01
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-0.67%
|
$0
$0.8 P/Share
|